Celldex Therapeutics reported 54.2M in Cost of Sales for its fiscal quarter ending in June of 2025.


Cost Of Sales Change Date
AbbVie USD 4.35B 344M Jun/2025
Amgen USD 3.01B 406M Jun/2025
Bristol-Myers Squibb USD 3.37B 339M Jun/2025
Celldex Therapeutics 54.2M 8.94M Jun/2025
Glaxosmithkline GBP 2.16B 363M Jun/2025
Pfizer USD 4.99B 2.4B Jun/2025
Roche Holding CHF 4.13B 393.5M Dec/2024